No Data
Rakuolia Pharmaceuticals---Received a one-time payment from Kyukou Pharmaceutical due to a dispute.
A rebound. It has been announced that Kyowa Kirin will receive a lump sum payment for a patch containing a new sodium channel blocker (RQ-00350215). The company will grant Kyowa Kirin exclusive rights to develop, manufacture, and sell the compound worldwide, and also hold the rights to receive milestone payments based on the development stage, sales royalties based on product revenue, and sales milestones after the product is launched. This time, Kyowa Kirin has achieved the development milestone.
Urban Font, Sumitomo Be, etc. (additional) Rating
Promotion - Bullish code Stock name Securities company Before After ------------------------------------------------<3281> GLP Yamato "2" "1" Target stock price change code Stock name Securities company Before After ------------------------------------------------<1812> Kashima Mizuho 2720 yen 3300 yen <2337> Ichigo SMBC Nikko 390 yen 420 yen <
Hisamitsu Pharmaceutical: Semi-annual report - Period 123 (2024/03/01 - 2025/02/28)
Volume Change Rate Ranking (9 o'clock) - Kyukoh Yakuhin, Koshidaka HD, etc. are ranked.
In the volume change rate ranking, by comparing the volume of the most recent 5 days with the volume on the delivery day, you can understand the market participants' interests in trends such as stockpiling. Top volume change rate [as of 9:32 on October 11] (comparison with the most recent 5-day average volume) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate <2625> iFTPX Year 4 207,692 107,185.08 301.98% 0.00
Hisamitsu Pharmaceutical Co. Reports Q2 Growth
Hisamitsu Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending February 2025 [Japanese GAAP] (consolidated)
No Data
No Data